{
  "id": 4039101,
  "title": "Bictegravir-Lenacapavir Combo Pill Earns FDA Approval in Suppressed HIV",
  "url": "https://urgent.news/2026/08/28/bictegravir-lenacapavir-combo-pill-earns-fda-approval-in-suppressed",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-28T20:50:02.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/infectiousdisease/hivaids/122817"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- The FDA approved the combination of bictegravir and lenacapavir (Bixlenvo) for adults with virologically suppressed HIV-1 infection, Gilead Sciences announced Thursday. The once-daily single tablet contains 75 mg of the integrase...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}